XML 21 R8.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements Of Cash Flows
 12 Months Ended
Feb. 26, 2021
USD ($)
Feb. 28, 2020
USD ($)
Feb. 22, 2019
USD ($)
OPERATING ACTIVITIES      
Net income $ 26,100,000 $ 199,700,000 $ 126,000,000.0
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 85,200,000 85,600,000 81,600,000
Goodwill, Impairment Loss 17,600,000 0 0
Restructuring costs 28,600,000 0 0
Loss (gain) on disposal of fixed assets 0 (19,600,000) 400,000
Deferred Income Tax Expense (Benefit) 15,900,000 12,100,000 (800,000)
Non-cash stock compensation 20,900,000 16,700,000 17,700,000
Equity in income of unconsolidated affiliates (9,300,000) (12,200,000) (13,700,000)
Dividends received from unconsolidated affiliates 8,100,000 12,500,000 9,100,000
Derivative, Loss on Derivative 0 0 (13,000,000.0)
Other (13,300,000) (200,000) (12,900,000)
Changes in operating assets and liabilities, net of acquisitions, divestures, and deconsolidations:      
Accounts receivable 120,900,000 7,200,000 (66,400,000)
Inventories 27,100,000 (6,200,000) (24,000,000.0)
Other assets (22,900,000) (1,900,000) 10,200,000
Accounts payable (69,000,000.0) 10,800,000 8,500,000
Employee compensation liabilities (138,700,000) 36,700,000 21,100,000
Increase (Decrease) in Obligation, Pension and Other Postretirement Benefits (22,600,000) (3,100,000) 4,000,000.0
Accrued expenses and other liabilities (9,800,000) 22,700,000 (16,600,000)
Net cash provided by operating activities 64,800,000 360,800,000 131,200,000
INVESTING ACTIVITIES      
Capital expenditures (41,300,000) (73,400,000) (81,400,000)
Proceeds from Sale of Property, Plant, and Equipment 7,400,000 1,800,000 20,500,000
Proceeds from liquidation of company owned life insurance 2,200,000 4,200,000 22,100,000
Proceeds from Divestiture of Businesses 0 72,600,000 (300,000)
Payments to Acquire Businesses, Net of Cash Acquired (3,800,000) (3,700,000) (226,200,000)
Other 4,900,000 3,000,000.0 (6,300,000)
Net cash provided by (used in) investing activities (30,600,000) 4,500,000 (271,600,000)
FINANCING ACTIVITIES      
Dividends paid (43,500,000) (69,100,000) (64,300,000)
Common stock repurchases (42,700,000) (8,700,000) (4,200,000)
Proceeds from Lines of Credit 250,000,000.0 0 323,100,000
Repayments of Lines of Credit (250,000,000.0) 0 (323,100,000)
Borrowings of long-term debt, net of issuance costs 0 0 450,000,000.0
Repayments of long-term debt (2,400,000) (2,900,000) (252,700,000)
Proceeds from (Payments for) Other Financing Activities 800,000 (1,200,000) (6,500,000)
Net cash used in financing activities (87,800,000) (81,900,000) 122,300,000
Effect of exchange rate changes on cash and cash equivalents 2,100,000 (1,100,000) (2,700,000)
Net increase (decrease) in cash and cash equivalents (51,500,000) 282,300,000 (20,800,000)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 495,600,000 [1] 547,100,000 [1],[2] 264,800,000 [1],[2]
Restricted Cash   6,100,000 3,500,000
Supplemental Cash Flow Information:      
Income taxes paid, net of refunds received 24,600,000 26,700,000 36,200,000
Interest paid, net of amounts capitalized $ 25,400,000 $ 24,500,000 $ 34,500,000
[1] These amounts include restricted cash of $5.8, $6.1 and $3.5 as of February 26, 2021, February 28, 2020 and February 22, 2019, respectively.
[2] These amounts include restricted cash of $6.1, $3.5 and $2.5 as of February 28, 2020, February 22, 2019 and February 23, 2018, respectively.